Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/7/2024 | Neutral | BTIG Research | |
| 3/8/2024 | $7.00 | Market Perform | TD Cowen |
| 1/2/2024 | Equal-Weight → Overweight | Stephens | |
| 7/10/2023 | $15.00 → $14.00 | Buy → Hold | Loop Capital |
| 10/24/2022 | $6.50 | Neutral → Underperform | BofA Securities |
| 7/12/2022 | $16.00 | Hold | Truist |
S-8 POS - Aaron's Company, Inc. (0001821393) (Filer)
S-8 POS - Aaron's Company, Inc. (0001821393) (Filer)
S-8 POS - Aaron's Company, Inc. (0001821393) (Filer)
ATLANTA, Oct. 3, 2024 /PRNewswire/ -- The Aaron's Company, Inc. ("The Aaron's Company" or "Aaron's") (NYSE:AAN) today announced the completion of its acquisition by IQVentures Holdings, LLC ("IQVentures"), a leading fintech organization, for $10.10 per share in cash, or an enterprise value of approximately $504 million. The acquisition was originally announced on June 17, 2024, and approved by The Aaron's Company shareholders on September 25, 2024. With the completion of the transaction, The Aaron's Company's common stock will cease trading as of today and will no longer be listed on the NYSE.
ATLANTA, Oct. 3, 2024 /PRNewswire/ -- The Aaron's Company, Inc. ("The Aaron's Company" or "Aaron's") (NYSE:AAN) and IQVentures Holdings, LLC ("IQVentures") today announced that they expect to complete the previously announced acquisition by IQVentures of The Aaron's Company later today. The acquisition was originally announced on June 17, 2024, and approved by The Aaron's Company shareholders on September 25, 2024. Upon completion of the transaction, The Aaron's Company's common stock will cease trading and will no longer be listed on the NYSE. Advisors J.P. Morgan Securities
ATLANTA, Aug. 5, 2024 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE:AAN) today released its second quarter 2024 financial results. Highlights of those results are included below, in the attached supplement, and at investor.aarons.com. Second Quarter 2024 Consolidated Results: Revenues were $503.1 millionNet loss was $11.9 millionAdjusted EBITDA1 was $24.5 millionLoss per share was $0.39; Non-GAAP loss per share1 was $0.07Key Business Highlights2: Announced the Company entered into a definitive agreement to be acquired by IQVentures Holdings, LLC for $10.10 per shareAaron's Business recurring revenue written increased 6.1% driven by 11.1% growth in lease m
ATLANTA, Oct. 3, 2024 /PRNewswire/ -- The Aaron's Company, Inc. ("The Aaron's Company" or "Aaron's") (NYSE:AAN) today announced the completion of its acquisition by IQVentures Holdings, LLC ("IQVentures"), a leading fintech organization, for $10.10 per share in cash, or an enterprise value of approximately $504 million. The acquisition was originally announced on June 17, 2024, and approved by The Aaron's Company shareholders on September 25, 2024. With the completion of the transaction, The Aaron's Company's common stock will cease trading as of today and will no longer be listed on the NYSE.
ATLANTA, Oct. 3, 2024 /PRNewswire/ -- The Aaron's Company, Inc. ("The Aaron's Company" or "Aaron's") (NYSE:AAN) and IQVentures Holdings, LLC ("IQVentures") today announced that they expect to complete the previously announced acquisition by IQVentures of The Aaron's Company later today. The acquisition was originally announced on June 17, 2024, and approved by The Aaron's Company shareholders on September 25, 2024. Upon completion of the transaction, The Aaron's Company's common stock will cease trading and will no longer be listed on the NYSE. Advisors J.P. Morgan Securities
ATLANTA, Aug. 5, 2024 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE:AAN) today released its second quarter 2024 financial results. Highlights of those results are included below, in the attached supplement, and at investor.aarons.com. Second Quarter 2024 Consolidated Results: Revenues were $503.1 millionNet loss was $11.9 millionAdjusted EBITDA1 was $24.5 millionLoss per share was $0.39; Non-GAAP loss per share1 was $0.07Key Business Highlights2: Announced the Company entered into a definitive agreement to be acquired by IQVentures Holdings, LLC for $10.10 per shareAaron's Business recurring revenue written increased 6.1% driven by 11.1% growth in lease m
ATLANTA, Sept. 13, 2023 /PRNewswire/ -- The Aaron's Company, Inc. (NYSE: AAN), a leading, technology-enabled, omnichannel provider of lease-to-own and retail purchase solutions, today announced the appointment of Wangdali (Wali) Bacdayan and Kristine (Kris) K. Malkoski to its Board of Directors effective on October 1, 2023. "On behalf of the entire Board of Directors, I would like to welcome Wali and Kris as the newest members of the Aaron's board," said John Robinson, chair of The Aaron's Company Board of Directors. "We believe their strong backgrounds and independence make t
4 - Aaron's Company, Inc. (0001821393) (Issuer)
4 - Aaron's Company, Inc. (0001821393) (Issuer)
4 - Aaron's Company, Inc. (0001821393) (Issuer)
SC 13G/A - Aaron's Company, Inc. (0001821393) (Subject)
SC 13G/A - Aaron's Company, Inc. (0001821393) (Subject)
SC 13G - Aaron's Company, Inc. (0001821393) (Subject)
BTIG Research initiated coverage of The Aaron's Company with a rating of Neutral
TD Cowen initiated coverage of The Aaron's Company with a rating of Market Perform and set a new price target of $7.00
Stephens upgraded The Aaron's Company from Equal-Weight to Overweight
4 - Aaron's Company, Inc. (0001821393) (Issuer)
4 - Aaron's Company, Inc. (0001821393) (Issuer)
4 - Aaron's Company, Inc. (0001821393) (Issuer)
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform. Fortress Biotech The Trade: Fortress Biotech, Inc. (NASDAQ:FBIO) President, CEO and Chairman Lindsay A MD Rosenwald acqui
During the last three months, 5 analysts shared their evaluations of Aarons (NYSE:AAN), revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 5 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 3 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 1 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $9.66, along with a high estimate of $10.10 and a low estimate of $8.00. This current average has increased b
Jefferies analyst Kyle Joseph downgrades Aarons (NYSE:AAN) from Buy to Hold and lowers the price target from $11 to $10.1.